FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/04/018454 [Registered on: 08/04/2019] Trial Registered Prospectively
Last Modified On: 02/04/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Screening 
Study Design  Single Arm Study 
Public Title of Study   Study of sleep related breathing disorders in patients with prolonged heart failure. 
Scientific Title of Study   Study of sleep disordered breathing in chronic heart failure patients 
Trial Acronym  SDBCHF 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SAJIT KISHAN GOLLAPALLI 
Designation  REGISTRAR 
Affiliation  kasturba medical college, manipal 
Address  DEPT. OF CARDIOLOGY, KMC, MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  9505666002  
Fax    
Email  sajitkishan1234@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR PADMAKUMAR RAMACHANDRAN 
Designation  Professor and head of unit 
Affiliation  kasturba medical college, manipal 
Address  DEPT. OF CARDIOLOGY, KMC, MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  9900921428  
Fax    
Email  padmakumar69@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  SAJIT KISHAN GOLLAPALLI 
Designation  REGISTRAR 
Affiliation  kasturba medical college, manipal 
Address  DEPT. OF CARDIOLOGY, KMC, MANIPAL

Udupi
KARNATAKA
576104
India 
Phone  9505666002  
Fax    
Email  sajitkishan1234@gmail.com  
 
Source of Monetary or Material Support  
LIFE PLUS MEDICAL Office.No.2-4-14B3, 1st Floor, Raaj Towers City Bus stand, Udupi - 576101  
 
Primary Sponsor  
Name  LIFE PLUS MEDICAL 
Address  LIFE PLUS MEDICAL Office.No.2-4-14B3, 1st Floor, Raaj Towers City Bus stand, Udupi - 576101  
Type of Sponsor  Other [MEDICAL EQUIPMENT COMPANY] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SAJIT KISHAN GOLLAPALLI  KASTURBA HOSPITAL  DEPARTMENT OF CARDIOLOGY, KASTURBA HOSPITAL & MEDICAL COLLEGE, MANIPAL-576104
Udupi
KARNATAKA 
9505666002

sajitkishan1234@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I509||Heart failure, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NOT APPLICABLE  NOT APPLICABLE 
Intervention  OVERNIGHT POLYSOMNOGRAPHY  IN HOSPITAL SCREENING FOR SLEEP DISORDERED BREATHING WITH OVERNIGHT POLYSOMNOGRAPHY 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  CHRONIC HEART FAILURE IN-HOSPITAL PATIENTS WHO HAVE RECOVERED FROM AN ACUTE DECOMPENSATION 
 
ExclusionCriteria 
Details  1.DECOMPENSATED HEART FAILURE PATIENTS REQUIRING OXYGEN SUPPORT.
2.RECENT ACUTE CORONARY SYNDROME (ACS) OR STROKE IN LAST 3 MONTHS.
3.PREGNANT WOMEN.
4.PATIENT WITH PREVIOUSLY DIAGNOSED SDB WHO ARE ON THERAPY
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
PREVALENCE OF SDB, PREVALENCE OF CSA AND OSA, IN CHRONIC HEART FAILURE IN-PATIENTS.  1 YEAR 
 
Secondary Outcome  
Outcome  TimePoints 
COMPARISON OF VARIOUS DEMOGRAPHIC PARAMETERS WITH PREVALENCE OF SDB.
 
1 YEAR 
CORRELATION OF LV DYSFUNCTION (LVEF) AND NTPROBNP LEVELS WITH AHI AND RDI.
 
1 YEAR 
CORRELATION OF ESS SCORES, STOP BANG SCORES, BERLIN QUESTIONNAIRE SCORES WITH AHI AND RDI.
 
1 YEAR 
ASSOCIATION OF VARIOUS CO-MORBIDITIES (TYPE 2 DIABETES, HTN, DYSLIPIDEMIA) WITH SDB.
 
1 YEAR 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   1. JavaheriS., et al., Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation, 1998. 97(21): p. 2154–2159 2. SinDD, FitzgeraldF, ParkerJD, et al: 1999. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101–1106 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   THIS RESEARCH PROJECT HAS BEEN STIMULATED BY ACCUMULATING EVIDENCE THAT SDB DISORDERS ARE IMPORTANT MODIFIERS OF DISEASE PROGRESSION AND TREATMENT IN PATIENTS WITH HEART FAILURE. HEART FAILURE PATIENTS HAVE OCCULT SDB, THEREFORE GO UNDETECTED. THE RESULTS OF THIS STUDY WOULD AID IN DETERMINING THE SAME, MODIFYING TREATMENT STRATEGIES AND ALSO IN ASCERTAINING THE ROLE OF REGULAR SCREENING OF SDB IN CHRONIC HEART FAILURE PATIENTS.
 PATIENTS WILL BE SCREENED USING SLEEP APNEA QUESTIONNAIRES. THEY WILL UNDERGO BASIC LAB EVALUATION AND CARDIAC EVALUATION FOLLOWING WHICH THEY WILL BE SUBJECTED TO  OVERNIGHT POLYSOMNOGRAPHY .THE STUDY WILL BE ANALYZED AND THE APNEA HYPOPNEA INDEX (AHI) AND RESPIRATORY DISTURBANCE INDEX (RDI) WILL BE DETERMINED AND PATIENTS WILL BE CLASSIFIED EITHER AS CENTRAL SLEEP APNEA (CSA) OR OBSTRUCTIVE SLEEP APNEA (OSA) . THE PREVALENCE OF SDB  WILL BE DETERMINED IN THE STUDY POPULATION AND THE ABOVE INDICES (AHI,  RDI )WILL BE COMPARED WITH HEART FAILURE SEVERITY CLASS. 
 
Close